Literature DB >> 23224247

Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis.

Isabelle Gorenne1, Sheetal Kumar, Kelly Gray, Nichola Figg, Haixiang Yu, John Mercer, Martin Bennett.   

Abstract

BACKGROUND: Vascular smooth muscle cells (VSMCs) in human atherosclerosis manifest extensive DNA damage and activation of the DNA damage response, a pathway that coordinates cell cycle arrest and DNA repair, or can trigger apoptosis or cell senescence. Sirtuin 1 deacetylase (SIRT1) regulates cell ageing and energy metabolism and regulates the DNA damage response through multiple targets. However, the direct role of SIRT1 in atherosclerosis and how SIRT1 in VSMCs might regulate atherosclerosis are unknown. METHODS AND
RESULTS: SIRT1 expression was reduced in human atherosclerotic plaques and VSMCs both derived from plaques and undergoing replicative senescence. SIRT1 inhibition reduced DNA repair and induced apoptosis, in part, through reduced activation of the repair protein Nijmegen Breakage Syndrome-1 but not p53. Fat feeding reduced SIRT1 and induced DNA damage in VSMCs. VSMCs from mice expressing inactive truncated SIRT1 (Δex4) showed increased oxidized low-density lipoprotein-induced DNA damage and senescence. ApoE(-/-) mice expressing SIRT1(Δex4) only in smooth muscle cells demonstrated increased DNA damage response activation and apoptosis, increased atherosclerosis, reduced relative fibrous cap thickness, and medial degeneration.
CONCLUSIONS: SIRT1 is reduced in human atherosclerosis and is a critical regulator of the DNA damage response and survival in VSMCs. VSMC SIRT1 protects against DNA damage, medial degeneration, and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224247     DOI: 10.1161/CIRCULATIONAHA.112.124404

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  89 in total

Review 1.  Vascular Smooth Muscle as a Target for Novel Therapeutics.

Authors:  Karen E Porter; Kirsten Riches
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

2.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

Review 3.  Ageing induced vascular smooth muscle cell senescence in atherosclerosis.

Authors:  Anna K Uryga; Martin R Bennett
Journal:  J Physiol       Date:  2015-09-16       Impact factor: 5.182

Review 4.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

5.  SIRT1 protects against aortic dissection by regulating AP-1/decorin signaling-mediated PDCD4 activation.

Authors:  Kefeng Zhang; Xudong Pan; Jun Zheng; Yongmin Liu; Lizhong Sun
Journal:  Mol Biol Rep       Date:  2020-02-18       Impact factor: 2.316

Review 6.  Sirtuins, aging, and cardiovascular risks.

Authors:  Gaia Favero; Lorenzo Franceschetti; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Age (Dordr)       Date:  2015-06-23

Review 7.  Histone Deacetylases and Cardiometabolic Diseases.

Authors:  Kan Hui Yiew; Tapan K Chatterjee; David Y Hui; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-16       Impact factor: 8.311

Review 8.  Mechanisms of Vascular Aging.

Authors:  Zoltan Ungvari; Stefano Tarantini; Anthony J Donato; Veronica Galvan; Anna Csiszar
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

Review 9.  Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases.

Authors:  Alice E Kane; David A Sinclair
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

10.  Pollen Typhae Total Flavone Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis in Human Aortic-Vascular Smooth Muscle Cells through Down-Regulating PERK-eIF2α-ATF4-CHOP Pathway.

Authors:  Ming-Tai Chen; Ruo-Lan Huang; Li-Jun Ou; Ying-Nan Chen; Ling Men; Xiao Chang; Ling Wang; Yu-Zhu Yang; Zhong Zhang
Journal:  Chin J Integr Med       Date:  2019-02-01       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.